Skip to main content
Equibles
GRDN logo

GRDN · Guardian Pharmacy Services, Inc. · Metrics

Track GRDN — free

Use GRDN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GRDN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$43.39 +0.94 (+2.21%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$2.67B
Shares
63.34M

GRDN metrics

60 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$42.45
Market cap
$2.67B

Price action

20 metrics
Price change (1W)
+9.2%
Price change (30D)
+2.4%
Price change (3M)
+1.5%
Price change (6M)
+26.2%
Price change (YTD)
+41.1%
Price change (1Y)
+47.1%
Trailing year
Price change (5Y)
—
52-week high
$43.83
52-week low
$23.41
Change from 52-week high
-3.1%
Change from 52-week low
+81.3%
Annualized volatility
41.4%
Annualized volatility (3M)
46.1%
Beta
0.8
RSI (14D)
66.6
Price vs SMA 50
+6.5%
Price vs SMA 200
+18.4%
Avg volume (3M)
402,346
Relative volume
1.6
Average dollar volume
$16.28M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
63.34M

Valuation

12 metrics
P / E (TTM)
40.5
Trailing earnings · reciprocal yield 2.5%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.8×
reciprocal yield 54.8%
P / book
10.4
reciprocal yield 9.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
27.0
reciprocal yield 3.7%
Earnings yield
2.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
21.6%
Operating margin
5.8%
Trailing 12 months
Net margin
4.5%
Gross profit (TTM)
$316.58M
Operating profit (TTM)
$85.44M
Net income (TTM)
$65.91M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
30.6%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+2.2%
Year over year
Net income growth YoY
+142.2%
Revenue (TTM)
$1.46B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
25.6%
Return on assets
14.9%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$108.80M
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
135.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$89.81M
Total assets
$443.58M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$98.86M
Capital expenditures (TTM)
$4.50M
R&D (TTM)
—
SG&A (TTM)
$231.14M
Stock compensation (TTM)
$10.23M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
188
13F filer change QoQ
+17
Institutional ownership
46.3%

Short interest

3 metrics
Short interest
4.7%
Latest settlement · 7.4 days to cover
Days to cover
7.4d
Short-squeeze score
81 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1802255 CUSIP 40145W101 13F (30d) 118 filings 118 filers Visit website Investor relations